Palvella Therapeutics (PVLA) Prepaid Assets (2013 - 2026)
Palvella Therapeutics (PVLA) reported Prepaid Assets of $1.4 million for Q1 2026, down 24.9% year-over-year from $1.8 million in Q1 2025, and up 37.11% on a QoQ basis from $1.0 million in Q4 2025.
Palvella Therapeutics (PVLA) has 14 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Prepaid Assets fell 24.9% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 24.9% YoY) and the FY2025 annual result came in at $1.0 million, down 56.23% from the prior year.
- Prepaid Assets rose to $1.4 million in Q1 2026 per PVLA's latest filing, from $1.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $11.1 million in Q1 2023 and bottomed at $198000.0 in Q4 2023.
- The 5-year median for Prepaid Assets is $2.3 million (2024), against an average of $4.3 million.
- Peak annual rise in Prepaid Assets reached 1059.6% in 2024, while the deepest fall reached 96.94% in 2024.
- Tracing PVLA's Prepaid Assets over 5 years: stood at $3.2 million in 2022, then tumbled by 93.84% to $198000.0 in 2023, then surged by 1059.6% to $2.3 million in 2024, then sank by 56.23% to $1.0 million in 2025, then soared by 37.11% to $1.4 million in 2026.
- Per Business Quant, the three latest PVLA Prepaid Assets figures stand at $1.4 million (Q1 2026), $1.0 million (Q4 2025), and $1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 649,000.00 |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 198,000.00 |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | 10.65 Mn |
| Mar 31, 2023 | 11.07 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 7.91 Mn |
| Jun 30, 2022 | 8.70 Mn |
| Mar 31, 2022 | 9.84 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Sep 30, 2021 | 5.95 Mn |
| Jun 30, 2021 | 5.77 Mn |
| Mar 31, 2021 | 5.63 Mn |
| Dec 31, 2020 | 3.58 Mn |
| Sep 30, 2020 | 3.07 Mn |
| Jun 30, 2020 | 4.10 Mn |
| Mar 31, 2020 | 4.34 Mn |
| Dec 31, 2019 | 4.07 Mn |
| Sep 30, 2019 | 4.78 Mn |
| Jun 30, 2019 | 4.61 Mn |
| Mar 31, 2019 | 6.38 Mn |
| Dec 31, 2018 | 4.57 Mn |
| Sep 30, 2018 | 4.21 Mn |
| Jun 30, 2018 | 3.07 Mn |
| Mar 31, 2018 | 3.19 Mn |
| Dec 31, 2017 | 1.62 Mn |
| Sep 30, 2017 | 2.82 Mn |
| Jun 30, 2017 | 3.95 Mn |
| Mar 31, 2017 | 3.48 Mn |
| Dec 31, 2016 | 3.26 Mn |
| Sep 30, 2016 | 4.58 Mn |
| Jun 30, 2016 | 3.51 Mn |
| Mar 31, 2016 | 3.61 Mn |
| Dec 31, 2015 | 2.31 Mn |
| Sep 30, 2015 | 589,928.00 |
| Jun 30, 2015 | 732,221.00 |
| Mar 31, 2015 | 507,390.00 |
| Dec 31, 2014 | 1.33 Mn |
| Dec 31, 2013 | 449,733.00 |